Anzeige
Mehr »
Login
Samstag, 16.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Kolumbiens nächster Kupferriese? Warum Investoren dieses 14.000-Meter-Bohrprogramm beobachten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XEDS | ISIN: US2697961082 | Ticker-Symbol: N/A
Frankfurt
04.10.24
08:17 Uhr
1,760 Euro
0,000
0,00 %
1-Jahres-Chart
EAGLE PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
EAGLE PHARMACEUTICALS INC 5-Tage-Chart

Aktuelle News zur EAGLE PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrEagle Pharmaceuticals, Inc.: Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration40WOODCLIFF LAKE, N.J., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq and OTCMKTS: EGRX) (the "Company" or "Eagle") today announced that it has notified The Nasdaq Stock Market...
► Artikel lesen
FrEAGLE PHARMACEUTICALS, INC. - 8-K, Current Report-
MiEAGLE PHARMACEUTICALS, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB-
DiEagle Pharmaceuticals names Christopher Krawtschuk as CFO1
31.10.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report16
EAGLE PHARMACEUTICALS Aktie jetzt für 0€ handeln
31.10.Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan109WOODCLIFF LAKE, N.J., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (the "Company" or "Eagle") (OTCMKTS: EGRX) today announced that its Board of Directors (the "Board") has adopted...
► Artikel lesen
11.10.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 11.10.2024336The following instruments on Boerse Frankfurt do have their last trading day on 11.10.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 11.10.2024.ISIN NameCA60872A1066...
► Artikel lesen
04.10.XFRA 1E6: AUSSETZUNG/SUSPENSION359DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEAGLE PHARMACEUTI.DL-...
► Artikel lesen
02.10.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report7
27.08.Eagle Pharmaceuticals receives delisting notification from Nasdaq5
27.08.Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq100WOODCLIFF LAKE, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the "Company" or "Eagle") today announced that it received a notice (the "Notice") on August 21...
► Artikel lesen
27.08.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report1
09.08.EAGLE PHARMACEUTICALS, INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB1
05.08.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report1
10.07.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report1
29.05.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report1
22.05.Eagle Pharmaceuticals receives delisting notification from Nasdaq3
22.05.EAGLE PHARMACEUTICALS, INC. - 8-K, Current Report-
22.05.Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq310WOODCLIFF LAKE, N.J., May 22, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the "Company" or "Eagle") today announced that it received a notice (the "Notice") on May 20, 2024...
► Artikel lesen
12.04.Eagle Pharmaceuticals, Inc.: Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K185WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the "Company") today announced that it received a notice (the "Notice") on April 8, 2024 from the...
► Artikel lesen
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1